Search results for query: *

  • Users: Autumnly
  • Content: Threads
  • Order by date
  1. Autumnly

    Cochrane Review: Cognitive Behavioural Therapy for Tinnitus

    Cognitive behavioural therapy for tinnitus Background Tinnitus affects up to 21% of the adult population with an estimated 1% to 3% experiencing severe problems. Cognitive behavioural therapy (CBT) is a collection of psychological treatments based on the cognitive and behavioural traditions in...
  2. Autumnly

    Clinical Advancements for Managing Hyperacusis with Pain

    Clinical Advancements for Managing Hyperacusis with Pain Pollard, Bryan The Hearing Journal: October 2019 - Volume 72 - Issue 10 - p 10,12 Like many who suffer from a rare disorder, hyperacusis sufferers frequently face clinicians who have an insufficient understanding of the most impacting...
  3. Autumnly

    UK Study Opportunity: Investigation of Executive Functioning in Adults with & without Tinnitus

    What is the purpose of this study? Researchers who investigate the ability to concentrate refer to the ability as “cognition”. Recent research suggests that people with tinnitus may perform differently on computer-based puzzles that measure different types of cognition. Tinnitus is the common...
  4. Autumnly

    Working in Preschool Increases the Risk of Hearing-Related Symptoms

    Working in preschool increases the risk of hearing-related symptoms: a cohort study among Swedish women PURPOSE: To assess whether working in preschools increases the risk of hearing-related symptoms and whether age, occupational noise, and stressful working conditions affect the risk...
  5. Autumnly

    Tinnitus (Severity) Is Associated With Cumulative Lifetime Sound Exposure

    Tinnitus Severity Is Related to the Sound Exposure of Symphony Orchestra Musicians Independently of Hearing Impairment Objectives: Tinnitus can be debilitating and with great impact of musicians professional and private life. The objectives of the study were therefore to: (1) describe the...
  6. Autumnly

    Cognosetta — Tinnitus and Hearing Disorder Therapeutics

    Cognosetta is a drug discovery company advancing pharmaceutical therapies for tinnitus and other hearing disorders. Our focus is the discovery and development of safe and effective medications. At Cognosetta, we value scientific research exploring ion channels as targets for neurological...
  7. Autumnly

    British Academy of Audiology (BAA) — 2018 Conference

    Photos are from David's twitter account. New European tinnitus guidelines funded by a @COSTprogramme (on twitter) grant soon to be published Top 10 Hyperacusis Research Priorities (what a joke) Tinnitus Care Options (by the BTA) Hyperacusis Management in Children "Cognitive...
  8. Autumnly

    The Incredibly Frustrating Reason There’s No Lyme Disease Vaccine

    The incredibly frustrating reason there’s no Lyme disease vaccine Your dog can get vaccinated for Lyme. You cannot. The deer tick spreads the bacteria that causes Lyme. Lyme has quickly become one of the most common infectious diseases in America, with many as 300,000 people infected every...
  9. Autumnly

    SAGE Therapeutics — CNS Disorders

    Sage Therapeutics "Sage Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders." SAGE-217 "SAGE-217 is a novel, selective...
  10. Autumnly

    Viola Player Sues Royal Opera House

    https://www.belfasttelegraph.co.uk/news/uk/viola-player-sues-royal-opera-house-over-hearing-damage-during-rehearsals-36548235.html Viola player sues Royal Opera House over ‘hearing damage’ during rehearsals Christopher Goldscheider says he has been devastated by the effects of ‘acoustic shock’...